Oct 26, 2026 08:01AM
Oct 24, 2026 10:30AM
Oct 21, 2026 08:02AM
Oct 21, 2026 08:01AM
Oct 5, 2026 01:25PM
Sep 29, 2026 08:02AM
Sep 29, 2026 08:01AM Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection
Sep 14, 2026 08:01AM
Aug 17, 2026 08:02AM
Aug 17, 2026 08:01AM
Aug 14, 2026 07:01AM
Aug 12, 2026 08:01AM
Aug 12, 2026 08:01AM
Aug 10, 2026 08:02AM Acurx partners with Leiden University to study MRSA antibiotic target
Aug 10, 2026 08:01AM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jul 14, 2026 08:00AM
Jul 8, 2026 08:00AM
Jun 16, 2026 08:02AM
Jun 16, 2026 08:00AM Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Develo
May 19, 2026 12:25PM
May 12, 2026 07:01AM
May 4, 2026 08:00AM
Apr 29, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 20, 2026 08:00AM
Apr 16, 2026 04:01PM Acurx Pharmaceuticals closes $2.5M offering with potential $4.6M more
Apr 16, 2026 04:01PM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 7, 2026 09:00AM
Mar 30, 2026 07:01AM
Mar 13, 2026 07:01AM Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
Mar 9, 2026 08:01AM
Feb 16, 2026 08:01AM
Feb 2, 2026 08:00AM
Nov 18, 2025 08:00AM
Nov 12, 2025 07:01AM
Nov 10, 2025 08:00AM
Oct 28, 2025 08:03AM ACURX presents data on antibiotic gut microbiome selectivity at conference
Oct 28, 2025 08:00AM
Oct 27, 2025 08:00AM
Oct 9, 2025 07:31AM
Oct 9, 2025 07:30AM
Oct 1, 2025 06:57AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
Sep 3, 2025 07:01AM

335,363 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All